Telix Pharmaceuticals Limited (TLPPF) Operating cash flow 2023–2025
Telix Pharmaceuticals Limited (TLPPF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$17.3MFY2025 · since FY2023: $14.3M → -$17.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.3M | -162.9% |
| FY2024 | $27.5M | +92.6% |
| FY2023 | $14.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLPPF financial trends
TLPPF RevenueTLPPF Net incomeTLPPF Net marginTLPPF Gross profitTLPPF Gross marginTLPPF Operating incomeTLPPF Operating marginTLPPF Free cash flowTLPPF Capital expendituresTLPPF Return on equityTLPPF Stock buybacksTLPPF Dividends paidTLPPF Total assetsTLPPF Total liabilitiesTLPPF Shareholders’ equityTLPPF overview →